E-LIB Suche - Ergebnisse für: Foglietta, M

1

MYOCARDIAL INFARCTION DUE TO LEFT CIRCUMFLEX ARTERY OCCLUSI..:

Ottaviani, A ; Foglietta, M ; Ricci, F...
European Heart Journal Supplements. 26 (2024) Supplement_2 - p. ii128-ii129 , 2024

Link: https://doi.org/10.1093/..

2

Biomechanical factors and atherosclerosis localization: ins..:

Bacigalupi, Elena ; Pizzicannella, Jacopo ; Rigatelli, Gianluca...
Frontiers in Cardiovascular Medicine. 11 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Adjuvant capecitabine in triple negative breast cancer pati..:

Di Lisa F. S ; Krasniqi E ; Pizzuti L...
info:eu-repo/semantics/altIdentifier/pmid/37260975. , 2023

Link: https://hdl.handle.net/1..

4

Ultrasound boosts doxorubicin efficacy against sensitive an..:

Foglietta F ; Macri M ; Panzanelli P...
info:eu-repo/semantics/altIdentifier/pmid/36632905. , 2023

Link: https://hdl.handle.net/2..

5

Adjuvant capecitabine in triple negative breast cancer pati..:

Di Lisa F. S ; Krasniqi E ; Pizzuti L...
info:eu-repo/semantics/altIdentifier/pmid/37260975. , 2023

Link: https://hdl.handle.net/1..

6

The evolving landscape of COVID-19 and post-COVID condition..:

Visentin A ; Chatzikonstantinou T ; Scarfo' L...
info:eu-repo/semantics/altIdentifier/pmid/37772428. , 2023

Link: https://hdl.handle.net/2..

7

Thrombotic and bleeding complications in patients with chro..:

Antic D ; Milic N ; Chatzikonstantinou T...
info:eu-repo/semantics/altIdentifier/pmid/36028857. , 2022

Link: http://hdl.handle.net/11..

8

Phase II study of eribulin in combination with gemcitabine ..:

Pellegrino, B. ; Cavanna, L. ; Boggiani, D....
ESMO Open. 6 (2021) 1 - p. 100019 , 2021

Link: https://doi.org/10.1016/..

9

Clinical outcome with different doses of low-molecular-weig..:

Mennuni, Marco G. ; Renda, Giulia ; Grisafi, Leonardo...
Journal of Thrombosis and Thrombolysis. 52 (2021) 3 - p. 782-790 , 2021

Link: https://doi.org/10.1007/..

10

COVID-19 severity and mortality in patients with CLL: an up..:

Chatzikonstantinou T ; Kapetanakis A ; Scarfo L...
info:eu-repo/semantics/altIdentifier/pmid/34725454. , 2021

Link: https://hdl.handle.net/1..

11

COVID-19 severity and mortality in patients with CLL: an up..:

Chatzikonstantinou, T ; Kapetanakis, A ; Scarfo, L...
https://cris.maastrichtuniversity.nl/en/publications/99ed176f-f1d4-420d-832e-526e9c502951. , 2021

Link: https://cris.maastrichtu..

12

COVID-19 severity and mortality in patients with CLL: an up..:

Chatzikonstantinou T ; Kapetanakis A ; Scarfo L...
info:eu-repo/semantics/altIdentifier/pmid/34725454. , 2021

Link: http://hdl.handle.net/11..

13

Management of chronic lymphocytic leukemia in Italy during ..:

Cuneo A ; Rigolin G. M ; Coscia M...
info:eu-repo/semantics/altIdentifier/pmid/34258787. , 2021

Link: https://hdl.handle.net/1..

14

Phase II study of eribulin in combination with gemcitabine ..:

Pellegrino, B ; Cavanna, L ; Boggiani, D...
info:eu-repo/semantics/altIdentifier/wos/WOS:000631402900017. , 2021

Link: https://hdl.handle.net/1..

15

COVID-19 severity and mortality in patients with CLL: an up..:

Chatzikonstantinou T ; Kapetanakis A ; Scarfo L...
info:eu-repo/semantics/altIdentifier/pmid/34725454. , 2021

Link: http://hdl.handle.net/24..